ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/06/15 | 2,064 | 2,081 | 2,061 | 2,061 | -3 | -0.1% | 58,200 |
2022/06/14 | 2,063 | 2,074 | 2,052 | 2,064 | -18 | -0.9% | 64,600 |
2022/06/13 | 2,071 | 2,091 | 2,060 | 2,082 | ±0 | ±0% | 46,600 |
2022/06/10 | 2,070 | 2,097 | 2,065 | 2,082 | -19 | -0.9% | 66,600 |
2022/06/09 | 2,108 | 2,116 | 2,096 | 2,101 | ±0 | ±0% | 55,600 |
2022/06/08 | 2,092 | 2,110 | 2,077 | 2,101 | +14 | +0.7% | 61,500 |
2022/06/07 | 2,079 | 2,097 | 2,076 | 2,087 | +19 | +0.9% | 53,300 |
2022/06/06 | 2,028 | 2,068 | 2,024 | 2,068 | +35 | +1.7% | 65,700 |
2022/06/03 | 2,039 | 2,050 | 2,025 | 2,033 | +12 | +0.6% | 71,000 |
2022/06/02 | 2,025 | 2,028 | 2,006 | 2,021 | -4 | -0.2% | 57,700 |
2022/06/01 | 1,992 | 2,034 | 1,992 | 2,025 | +39 | +2% | 56,900 |
2022/05/31 | 2,033 | 2,041 | 1,983 | 1,986 | -50 | -2.5% | 96,600 |
2022/05/30 | 1,997 | 2,036 | 1,989 | 2,036 | +54 | +2.7% | 277,500 |
2022/05/27 | 1,998 | 1,998 | 1,964 | 1,982 | +7 | +0.4% | 115,000 |
2022/05/26 | 1,978 | 1,992 | 1,971 | 1,975 | -3 | -0.2% | 47,900 |
2022/05/25 | 1,990 | 1,993 | 1,972 | 1,978 | -2 | -0.1% | 58,200 |
2022/05/24 | 1,991 | 1,991 | 1,962 | 1,980 | -23 | -1.1% | 65,400 |
2022/05/23 | 2,011 | 2,025 | 1,986 | 2,003 | +21 | +1.1% | 85,000 |
2022/05/20 | 1,993 | 2,004 | 1,974 | 1,982 | -11 | -0.6% | 67,100 |
2022/05/19 | 1,973 | 1,998 | 1,970 | 1,993 | -10 | -0.5% | 35,700 |
2022/05/18 | 1,999 | 2,006 | 1,980 | 2,003 | +6 | +0.3% | 42,100 |
2022/05/17 | 2,005 | 2,037 | 1,991 | 1,997 | ±0 | ±0% | 81,500 |
2022/05/16 | 2,076 | 2,080 | 1,990 | 1,997 | -56 | -2.7% | 73,800 |
2022/05/13 | 2,041 | 2,057 | 1,997 | 2,053 | +11 | +0.5% | 80,000 |
2022/05/12 | 2,051 | 2,068 | 2,004 | 2,042 | +71 | +3.6% | 146,500 |
2022/05/11 | 1,977 | 1,977 | 1,950 | 1,971 | -9 | -0.5% | 37,100 |
2022/05/10 | 1,976 | 1,983 | 1,948 | 1,980 | -4 | -0.2% | 33,100 |
2022/05/09 | 2,016 | 2,016 | 1,981 | 1,984 | -32 | -1.6% | 48,400 |
2022/05/06 | 1,999 | 2,033 | 1,980 | 2,016 | +12 | +0.6% | 67,700 |
2022/05/02 | 1,993 | 2,005 | 1,973 | 2,004 | +14 | +0.7% | 57,100 |
2022/04/28 | 1,931 | 1,991 | 1,926 | 1,990 | +69 | +3.6% | 63,300 |
2022/04/27 | 1,915 | 1,949 | 1,900 | 1,921 | -12 | -0.6% | 258,100 |
2022/04/26 | 1,936 | 1,952 | 1,930 | 1,933 | +6 | +0.3% | 69,400 |
2022/04/25 | 1,907 | 1,931 | 1,905 | 1,927 | -4 | -0.2% | 44,900 |
2022/04/22 | 1,926 | 1,941 | 1,921 | 1,931 | -24 | -1.2% | 21,400 |
2022/04/21 | 1,925 | 1,956 | 1,925 | 1,955 | +33 | +1.7% | 46,200 |
2022/04/20 | 1,939 | 1,940 | 1,904 | 1,922 | +7 | +0.4% | 51,500 |
2022/04/19 | 1,934 | 1,936 | 1,910 | 1,915 | -24 | -1.2% | 46,100 |
2022/04/18 | 1,941 | 1,941 | 1,907 | 1,939 | -29 | -1.5% | 49,100 |
2022/04/15 | 1,968 | 1,980 | 1,950 | 1,968 | +3 | +0.2% | 45,300 |
2022/04/14 | 1,942 | 1,968 | 1,940 | 1,965 | +7 | +0.4% | 42,400 |
2022/04/13 | 1,941 | 1,959 | 1,922 | 1,958 | +36 | +1.9% | 64,800 |
2022/04/12 | 1,940 | 1,940 | 1,919 | 1,922 | -22 | -1.1% | 66,300 |
2022/04/11 | 1,929 | 1,947 | 1,924 | 1,944 | +13 | +0.7% | 56,700 |
2022/04/08 | 1,907 | 1,938 | 1,893 | 1,931 | +36 | +1.9% | 132,800 |
2022/04/07 | 1,872 | 1,895 | 1,860 | 1,895 | +10 | +0.5% | 63,600 |
2022/04/06 | 1,899 | 1,902 | 1,882 | 1,885 | -23 | -1.2% | 84,000 |
2022/04/05 | 1,934 | 1,935 | 1,902 | 1,908 | -19 | -1% | 68,800 |
2022/04/04 | 1,921 | 1,940 | 1,905 | 1,927 | +6 | +0.3% | 45,700 |
2022/04/01 | 1,912 | 1,921 | 1,879 | 1,921 | +17 | +0.9% | 68,800 |
601~
650
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム